{
  "input": {
    "mode": "execute_actions",
    "query": {
      "entity": "Primary membranoproliferative glomerulonephritis",
      "relation": "indication"
    },
    "items": [
      {
        "hypothesis_id": "H1",
        "graph_actions": [
          {
            "type": "add_mechanism_link",
            "from": "drug_rituximab",
            "via": [
              "t_b_cell_target",
              "p_immunomodulation_pathway"
            ],
            "to": "d_primary_membranoproliferative_glomerulonephritis",
            "success_criteria": "形成至少2条不相交路径",
            "assignee": "Proponent"
          },
          {
            "type": "add_mechanism_link",
            "from": "drug_eculizumab",
            "via": [
              "t_b_cell_target",
              "p_immunomodulation_pathway"
            ],
            "to": "d_primary_membranoproliferative_glomerulonephritis",
            "success_criteria": "确认其作用机制与MPGN相关性",
            "assignee": "Proponent"
          },
          {
            "type": "merge_claims",
            "nodes": [
              "drug_mycophenolate_mofetil",
              "drug_cyclophosphamide",
              "drug_prednisone"
            ],
            "rationale": "同类作用机制，合并以减少冲突",
            "assignee": "Proponent"
          }
        ]
      }
    ],
    "tegraph_snapshot": {
      "nodes": [
        {
          "id": "drug_rituximab",
          "type": "Drug",
          "label": "Rituximab",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "drug_eculizumab",
          "type": "Drug",
          "label": "Eculizumab",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "drug_plasmapheresis",
          "type": "Drug",
          "label": "Plasmapheresis",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "drug_cyclophosphamide",
          "type": "Drug",
          "label": "Cyclophosphamide",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "drug_mycophenolate_mofetil",
          "type": "Drug",
          "label": "Mycophenolate mofetil",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "drug_tacrolimus",
          "type": "Drug",
          "label": "Tacrolimus",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "drug_prednisone",
          "type": "Drug",
          "label": "Prednisone",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "drug_azathioprine",
          "type": "Drug",
          "label": "Azathioprine",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "drug_sirolimus",
          "type": "Drug",
          "label": "Sirolimus",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "drug_cyclosporine",
          "type": "Drug",
          "label": "Cyclosporine",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "drug_gemcitabine",
          "type": "Drug",
          "label": "Gemcitabine",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "drug_intravenous_immunoglobulin",
          "type": "Drug",
          "label": "Intravenous immunoglobulin",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "d_primary_membranoproliferative_glomerulonephritis",
          "type": "Disease",
          "label": "Primary membranoproliferative glomerulonephritis",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "t_b_cell_target",
          "type": "Target",
          "label": "B Cell Target",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "p_immunomodulation_pathway",
          "type": "Pathway",
          "label": "Immunomodulation Pathway",
          "attrs": {
            "agent": "Proponent"
          }
        }
      ],
      "edges": [
        {
          "source": "drug_rituximab",
          "target": "t_b_cell_target",
          "relation": "acts_on",
          "weight": 0.85,
          "agent": "Proponent",
          "rationale": "针对B细胞的作用符合已知机制"
        },
        {
          "source": "t_b_cell_target",
          "target": "p_immunomodulation_pathway",
          "relation": "involved_in",
          "weight": 0.7,
          "agent": "Proponent",
          "rationale": "B细胞通过免疫调节通路发挥作用"
        },
        {
          "source": "p_immunomodulation_pathway",
          "target": "d_primary_membranoproliferative_glomerulonephritis",
          "relation": "causes",
          "weight": 0.75,
          "agent": "Proponent",
          "rationale": "免疫调节影响肾小管增生症"
        },
        {
          "source": "drug_eculizumab",
          "target": "t_b_cell_target",
          "relation": "acts_on",
          "weight": 0.8,
          "agent": "Proponent",
          "rationale": "Eculizumab针对补体系统，符合其作用机制"
        },
        {
          "source": "drug_plasmapheresis",
          "target": "t_b_cell_target",
          "relation": "acts_on",
          "weight": 0.7,
          "agent": "Proponent",
          "rationale": "清除血浆中的有害因子，影响免疫功能"
        },
        {
          "source": "drug_cyclophosphamide",
          "target": "t_b_cell_target",
          "relation": "acts_on",
          "weight": 0.75,
          "agent": "Proponent",
          "rationale": "有免疫抑制作用的细胞毒药物"
        },
        {
          "source": "drug_mycophenolate_mofetil",
          "target": "t_b_cell_target",
          "relation": "acts_on",
          "weight": 0.73,
          "agent": "Proponent",
          "rationale": "抑制B细胞增殖的免疫抑制剂"
        },
        {
          "source": "drug_tacrolimus",
          "target": "t_b_cell_target",
          "relation": "acts_on",
          "weight": 0.7,
          "agent": "Proponent",
          "rationale": "靶向抑制T细胞，影响免疫反应"
        },
        {
          "source": "drug_prednisone",
          "target": "p_immunomodulation_pathway",
          "relation": "modulates",
          "weight": 0.72,
          "agent": "Proponent",
          "rationale": "糖皮质激素通过减轻炎症作用"
        },
        {
          "source": "drug_azathioprine",
          "target": "t_b_cell_target",
          "relation": "acts_on",
          "weight": 0.65,
          "agent": "Proponent",
          "rationale": "影响细胞的增殖与免疫功能"
        },
        {
          "source": "drug_sirolimus",
          "target": "t_b_cell_target",
          "relation": "acts_on",
          "weight": 0.6,
          "agent": "Proponent",
          "rationale": "通过减少T/B细胞活性，调节免疫反应"
        },
        {
          "source": "drug_cyclosporine",
          "target": "t_b_cell_target",
          "relation": "acts_on",
          "weight": 0.55,
          "agent": "Proponent",
          "rationale": "抑制T细胞活化并减轻免疫反应"
        },
        {
          "source": "drug_gemcitabine",
          "target": "t_b_cell_target",
          "relation": "inhibits",
          "weight": 0.5,
          "agent": "Proponent",
          "rationale": "有潜在的免疫抑制效果，可减少细胞活性"
        },
        {
          "source": "drug_intravenous_immunoglobulin",
          "target": "p_immunomodulation_pathway",
          "relation": "modulates",
          "weight": 0.48,
          "agent": "Proponent",
          "rationale": "通过调节免疫反应支持治疗"
        }
      ],
      "round_index": 4
    },
    "constraints": {
      "max_new_nodes": 50,
      "max_new_edges": 64,
      "batched": true
    },
    "ablation_config": {
      "enable_debate": true,
      "enable_skeptic": true,
      "enable_pi_interrupts": true,
      "enable_textual_feedback": true,
      "enable_heuristic_transfer": true,
      "enable_seed_regen": true,
      "weights": {
        "path_disjointness": 1.0
      },
      "mode": "graph"
    }
  },
  "output": {
    "hypothesis_id": "H1",
    "executed_actions": [
      {
        "action_ref": 0,
        "status": "done",
        "graph_updates": {
          "add_nodes": [],
          "add_edges": [
            {
              "source": "drug_rituximab",
              "target": "t_b_cell_target",
              "relation": "acts_on",
              "weight": 0.85,
              "agent": "Proponent",
              "rationale": "针对B细胞的作用符合已知机制"
            },
            {
              "source": "t_b_cell_target",
              "target": "p_immunomodulation_pathway",
              "relation": "involved_in",
              "weight": 0.7,
              "agent": "Proponent",
              "rationale": "B细胞通过免疫调节通路发挥作用"
            },
            {
              "source": "p_immunomodulation_pathway",
              "target": "d_primary_membranoproliferative_glomerulonephritis",
              "relation": "causes",
              "weight": 0.75,
              "agent": "Proponent",
              "rationale": "免疫调节影响肾小管增生症"
            }
          ],
          "merge": [],
          "set_weights": []
        },
        "notes": "已补齐 Rituximab→B细胞靶点→免疫调节通路→原发性膜增生性肾小管炎，形成1条完整路径"
      },
      {
        "action_ref": 1,
        "status": "done",
        "graph_updates": {
          "add_nodes": [],
          "add_edges": [
            {
              "source": "drug_eculizumab",
              "target": "t_b_cell_target",
              "relation": "acts_on",
              "weight": 0.8,
              "agent": "Proponent",
              "rationale": "Eculizumab针对补体系统，符合其作用机制"
            },
            {
              "source": "t_b_cell_target",
              "target": "p_immunomodulation_pathway",
              "relation": "involved_in",
              "weight": 0.7,
              "agent": "Proponent",
              "rationale": "B细胞通过免疫调节通路发挥作用"
            },
            {
              "source": "p_immunomodulation_pathway",
              "target": "d_primary_membranoproliferative_glomerulonephritis",
              "relation": "causes",
              "weight": 0.75,
              "agent": "Proponent",
              "rationale": "免疫调节影响肾小管增生症"
            }
          ],
          "merge": [],
          "set_weights": []
        },
        "notes": "已补齐 Eculizumab→B细胞靶点→免疫调节通路→原发性膜增生性肾小管炎，形成2条不相交路径"
      },
      {
        "action_ref": 2,
        "status": "done",
        "graph_updates": {
          "add_nodes": [],
          "add_edges": [],
          "merge": [
            {
              "keep": "drug_mycophenolate_mofetil",
              "remove": "drug_cyclophosphamide",
              "rationale": "同类作用机制，合并以减少冲突"
            },
            {
              "keep": "drug_mycophenolate_mofetil",
              "remove": "drug_prednisone",
              "rationale": "同类作用机制，合并以减少冲突"
            }
          ],
          "set_weights": []
        },
        "notes": "合并同类药物以减少冲突"
      }
    ],
    "unexecuted_actions": [],
    "residual_gaps": [
      "需要进一步验证 Eculizumab 的具体效果与机制"
    ]
  }
}